Clinical Trials · NCT07713992

Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide

Name: Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

Not Yet RecruitingN/ASemaglutide Mazdutide

Phase: N/A
Recruitment status: Not Yet Recruiting
Sponsor: Tianjin Medical University
Enrollment: 72
Start date: Sep 2026
Locations: See registry
Primary endpoint: Absolute change in liver fat content measured by MRI-PDFF

View Semaglutide compound reference